The FREEDOM Study: a Randomised Controlled Trial of Sunlight and Calcium in Older People
This study has been completed.
Sponsor:
University of Sydney
Information provided by:
University of Sydney
ClinicalTrials.gov Identifier:
NCT00322166
First received: May 4, 2006
Last updated: October 20, 2009
Last verified: October 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The proposed study will determine the effect of a public health strategy (ie. increased sun light exposure and increased calcium intake) to reduce falls in older people in residential care using a randomised trial. The primary hypothesis of the trial is that increased appropriate sun light exposure will reduce falls, improve 25 hydroxy vitamin D (25OHD) levels and lower parathyroid hormone (PTH) levels. Secondary hypotheses are that the intervention will reduce accelerated bone turnover, reduce fractures, improve motor function and improve mood.
| Condition | Intervention |
|---|---|
|
Accidental Falls |
Other: Sunlight Other: Sunlight and calcium Other: control |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Factorial Assignment Masking: Open Label Primary Purpose: Prevention |
| Official Title: | A Randomised Controlled Trial of Sunlight and Calcium Supplementation to Reduce Vitamin D Deficiency and Falls in Older People in Residential Care |
Resource links provided by NLM:
Further study details as provided by University of Sydney:
Primary Outcome Measures:
- Falls [ Time Frame: 1 year ] [ Designated as safety issue: Yes ]
Secondary Outcome Measures:
- Vit D [ Time Frame: 1 year ] [ Designated as safety issue: No ]
- Fractures [ Time Frame: 1 year ] [ Designated as safety issue: Yes ]
- Geriatric Depression [ Time Frame: 1 year ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 600 |
| Study Start Date: | July 2006 |
| Study Completion Date: | December 2008 |
| Primary Completion Date: | November 2008 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Group A, Sunlight
Participants in this arm are required to sit in the sun most days of the week for 15 minutes
|
Other: Sunlight
Subjects in the intervention groups will be asked to undergo exposure of approximately 15% of their body (ie the face, hands and arms) usually between 9.30am - 10am daily during the year, 5 days per week.
|
|
Active Comparator: Group B, sunlight and calcium
Participants in this group receive sunlight and a calcium supplement
|
Other: Sunlight and calcium
Subjects in the intervention groups will be asked to undergo exposure of approximately 15% of their body (ie the face, hands and arms) usually between 9.30am - 10am daily during the year, 5 days per week. In the calcium and sunlight arm, calcium supplements (Caltrate, 600mg elemental calcium, Whitehall) will be administered to the whole group via the Blister/ Webster packs.
|
|
No Intervention: Group C
Control group
|
Other: control
Subjects in the control group will be provided with a brochure about vitamin D deficiency and how to treat it. They will receive their usual routine care and nutrition.
|
Show Detailed Description
Eligibility| Ages Eligible for Study: | 70 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- Aged 70 years or more
- Ambulant
- Likely to survive for more than 12 months, as assessed by the Implicit Review Tool employed in the FREE study
- Not taking vitamin D or calcium supplements
- No history of skin cancer in last three years
Exclusion Criteria:
- History of skin cancer in last three years
- Taking vitamin D or calcium supplements
- Not ambulant
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00322166
Locations
| Australia, New South Wales | |
| Royal North Shore Hospital | |
| Sydney, New South Wales, Australia, 2065 | |
Sponsors and Collaborators
University of Sydney
Investigators
| Principal Investigator: | Philip Sambrook, MD | University of Sydney |
More Information
No publications provided by University of Sydney
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Prof Philip Sambrook, University of Sydney |
| ClinicalTrials.gov Identifier: | NCT00322166 History of Changes |
| Other Study ID Numbers: | 402639, 0512-240M |
| Study First Received: | May 4, 2006 |
| Last Updated: | October 20, 2009 |
| Health Authority: | Australia: National Health and Medical Research Council |
Keywords provided by University of Sydney:
|
accidental falls vitamin D parathyroid hormone osteoporosis |
Additional relevant MeSH terms:
|
Vitamin D Deficiency Avitaminosis Deficiency Diseases Malnutrition Nutrition Disorders Calcium, Dietary Vitamin D |
Vitamins Bone Density Conservation Agents Physiological Effects of Drugs Pharmacologic Actions Micronutrients Growth Substances |
ClinicalTrials.gov processed this record on June 17, 2013